UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antibodies Against Laminaribioside and Chitobioside Are Novel Serologic Markers in Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2006-08, Vol.131 (2), p.366-378

2006

Volltextzugriff (PDF)

Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis

PloS one, 2011-05, Vol.6 (5), p.e18172-e18172

2011

Volltextzugriff (PDF)

Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis

PloS one, 2013-03, Vol.8 (3), p.e59953

2013

Volltextzugriff (PDF)

New serological markers in inflammatory bowel disease are associated with complicated disease behaviour

Gut, 2007-10, Vol.56 (10), p.1394-1403

2007

Volltextzugriff (PDF)

Creation of a gene expression classifier for predicting Parkinson’s disease rate of progression

Journal of Neural Transmission, 2020-05, Vol.127 (5), p.755-762

2020

Volltextzugriff (PDF)

Mir Expression Profile of Peripheral Blood Lymphocytes Predicts Relapse in Pediatric Acute Lymphoblastic Leukemia

Blood, 2016-12, Vol.128 (22), p.1736-1736

2016

Volltextzugriff (PDF)

Association of the novel serologic anti‐glycan antibodies anti‐laminarin and anti‐chitin with complicated Crohn's disease behavior

Inflammatory bowel diseases, 2010-02, Vol.16 (2), p.263-274

2010

Volltextzugriff (PDF)

The Relationships Among Objective and Subjective Environmental Stress Levels and Serum Uric Acid: The Moderating Effect of Perceived Control

Journal of occupational health psychology, 2000-07, Vol.5 (3), p.374-385

2000

Volltextzugriff (PDF)

Serum anti‐glycan antibodies predict complicated Crohn's disease behavior: A cohort study

Inflammatory bowel diseases, 2010-08, Vol.16 (8), p.1367-1375

2010

Volltextzugriff (PDF)

New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort

The American journal of gastroenterology, 2008-03, Vol.103 (3), p.665-681

2008

Volltextzugriff (PDF)

Novel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and Phenotype

The American journal of gastroenterology, 2009-06, Vol.104 (6), p.1426-1434

2009

Volltextzugriff (PDF)

Anti-Glycan Antibodies as Biomarkers for Diagnosis and Prognosis

Lupus, 2006-01, Vol.15 (7), p.442-450

2006

Volltextzugriff (PDF)

Blood IgM Anti-GAGA4 in the Diagnosis of Multiple Sclerosis (P03.240)

Neurology, 2013-02, Vol.80 (7_supplement)

2013

Volltextzugriff (PDF)

A new kind of carbohydrate array, its use for profiling antiglycan antibodies, and the discovery of a novel human cellulose-binding antibody

Glycobiology (Oxford), 2003-11, Vol.13 (11), p.749-754

2003

Volltextzugriff (PDF)

Anti-GalNAcβ: A novel anti-glycan autoantibody associated with pregnancy loss in women with antiphospholipid syndrome and in a mouse experimental model

Journal of autoimmunity, 2012-12, Vol.39 (4), p.420-427

2012

Volltextzugriff (PDF)

Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases

Journal of neuroimmunology, 2009-12, Vol.217 (1), p.95-101

2009

Volltextzugriff (PDF)

Intact cell adhesion to glycan microarrays

Glycobiology (Oxford), 2004-02, Vol.14 (2), p.197-203

2004

Volltextzugriff (PDF)

Serum anti-Glc(α1,4)Glc(α) antibodies as a biomarker for relapsing–remitting multiple sclerosis

Journal of the neurological sciences, 2006-05, Vol.244 (1), p.59-68

2006

Volltextzugriff (PDF)

Self-Assembly of a Tetrahedral Lectin into Predesigned Diamondlike Protein Crystals

Angewandte Chemie (International ed.), 1999-08, Vol.38 (16), p.2363-2366

1999

Volltextzugriff (PDF)

T1289 Anti-Glycan Antibodies are Associated With Disabling Disease Course and Complicated Disease Behavior in Patients With Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-529-S-529

2010

Volltextzugriff (PDF)

S2016 Serum Anti-Glycan Antibodies Can Contribute to Differential Diagnosis and Disease Stratification of Pediatric Crohn's Disease Patients

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-301-S-302

2010

Volltextzugriff (PDF)

T1257 Characterization of Changes of Serum Anti-Glycan Antibodies in Individual Patients Over Time in Inflammatory Bowel Disease (IBD)

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-522-S-522

2010

Volltextzugriff (PDF)

390 The Novel Anti-Glycan Antibodies Anti-L and Anti-C in Conjunction with ALCA, ACCA, gASCA and AMCA Predict Early Development of Fistulae, Stenoses and Surgery in Patients with Crohn's Disease: A Prospective Analysis

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-53-A-53

2008

Volltextzugriff (PDF)

392 Specific Levels and Combinations of the Anti-Glycan Antibodies Anti-L, Anti-C, ALCA, ACCA, gASCA and AMCA Contribute to Diagnosis and Differential Diagnosis of Patients with Crohn's Disease and Are Associated with Complicated Disease and Surgery

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-53-A-53

2008

Volltextzugriff (PDF)

S1257 Anti-Glycan Antibodies in Celiac Disease Before and After Gluten-Free Diet

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-212-A-212

2008

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(79)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Antibodies Against Laminaribioside and Chitobioside Are Novel Serologic Markers in Crohn’s Disease

Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis

Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis

New serological markers in inflammatory bowel disease are associated with complicated disease behaviour

Creation of a gene expression classifier for predicting Parkinson’s disease rate of progression

Mir Expression Profile of Peripheral Blood Lymphocytes Predicts Relapse in Pediatric Acute Lymphoblastic Leukemia

Association of the novel serologic anti‐glycan antibodies anti‐laminarin and anti‐chitin with complicated Crohn's disease behavior

The Relationships Among Objective and Subjective Environmental Stress Levels and Serum Uric Acid: The Moderating Effect of Perceived Control

Serum anti‐glycan antibodies predict complicated Crohn's disease behavior: A cohort study

New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort

Novel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and Phenotype

Anti-Glycan Antibodies as Biomarkers for Diagnosis and Prognosis

Blood IgM Anti-GAGA4 in the Diagnosis of Multiple Sclerosis (P03.240)

A new kind of carbohydrate array, its use for profiling antiglycan antibodies, and the discovery of a novel human cellulose-binding antibody

Anti-GalNAcβ: A novel anti-glycan autoantibody associated with pregnancy loss in women with antiphospholipid syndrome and in a mouse experimental model

Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases

Intact cell adhesion to glycan microarrays

Serum anti-Glc(α1,4)Glc(α) antibodies as a biomarker for relapsing–remitting multiple sclerosis

Self-Assembly of a Tetrahedral Lectin into Predesigned Diamondlike Protein Crystals

T1289 Anti-Glycan Antibodies are Associated With Disabling Disease Course and Complicated Disease Behavior in Patients With Crohn's Disease

S2016 Serum Anti-Glycan Antibodies Can Contribute to Differential Diagnosis and Disease Stratification of Pediatric Crohn's Disease Patients

T1257 Characterization of Changes of Serum Anti-Glycan Antibodies in Individual Patients Over Time in Inflammatory Bowel Disease (IBD)

390 The Novel Anti-Glycan Antibodies Anti-L and Anti-C in Conjunction with ALCA, ACCA, gASCA and AMCA Predict Early Development of Fistulae, Stenoses and Surgery in Patients with Crohn's Disease: A Prospective Analysis

392 Specific Levels and Combinations of the Anti-Glycan Antibodies Anti-L, Anti-C, ALCA, ACCA, gASCA and AMCA Contribute to Diagnosis and Differential Diagnosis of Patients with Crohn's Disease and Are Associated with Complicated Disease and Surgery

S1257 Anti-Glycan Antibodies in Celiac Disease Before and After Gluten-Free Diet

Suchergebnisse filtern